AU2009316226B2 - Agents and treatment for snoring and respiratory effort related arousals in sleep - Google Patents

Agents and treatment for snoring and respiratory effort related arousals in sleep Download PDF

Info

Publication number
AU2009316226B2
AU2009316226B2 AU2009316226A AU2009316226A AU2009316226B2 AU 2009316226 B2 AU2009316226 B2 AU 2009316226B2 AU 2009316226 A AU2009316226 A AU 2009316226A AU 2009316226 A AU2009316226 A AU 2009316226A AU 2009316226 B2 AU2009316226 B2 AU 2009316226B2
Authority
AU
Australia
Prior art keywords
subject
aureus
snoring
sleep
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2009316226A
Other languages
English (en)
Other versions
AU2009316226A1 (en
Inventor
Phillip Comans
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2008905902A external-priority patent/AU2008905902A0/en
Application filed by Individual filed Critical Individual
Priority to AU2009316226A priority Critical patent/AU2009316226B2/en
Publication of AU2009316226A1 publication Critical patent/AU2009316226A1/en
Application granted granted Critical
Publication of AU2009316226B2 publication Critical patent/AU2009316226B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/04—Nitro compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/07—Bacillus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Neurosurgery (AREA)
  • Oncology (AREA)
  • Anesthesiology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Otolaryngology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2009316226A 2008-11-13 2009-11-09 Agents and treatment for snoring and respiratory effort related arousals in sleep Ceased AU2009316226B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2009316226A AU2009316226B2 (en) 2008-11-13 2009-11-09 Agents and treatment for snoring and respiratory effort related arousals in sleep

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
AU2008905902 2008-11-13
AU2008905902A AU2008905902A0 (en) 2008-11-13 Treatment for snoring and respiratory effort related arousals in sleep
PCT/AU2009/001451 WO2010054424A1 (en) 2008-11-13 2009-11-09 Agents and treatment for snoring and respiratory effort related arousals in sleep
AU2009316226A AU2009316226B2 (en) 2008-11-13 2009-11-09 Agents and treatment for snoring and respiratory effort related arousals in sleep

Publications (2)

Publication Number Publication Date
AU2009316226A1 AU2009316226A1 (en) 2010-05-20
AU2009316226B2 true AU2009316226B2 (en) 2015-08-13

Family

ID=42169525

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2009316226A Ceased AU2009316226B2 (en) 2008-11-13 2009-11-09 Agents and treatment for snoring and respiratory effort related arousals in sleep

Country Status (8)

Country Link
US (1) US20110311588A1 (Direct)
EP (1) EP2358385A4 (Direct)
JP (2) JP2012508693A (Direct)
KR (1) KR20110112803A (Direct)
CN (1) CN102281894A (Direct)
AU (1) AU2009316226B2 (Direct)
CA (1) CA2743649A1 (Direct)
WO (1) WO2010054424A1 (Direct)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10022083B2 (en) 2011-06-02 2018-07-17 Abdulmohsen E. A. H. Al-Terki Multiple oral and nasal surgical procedures method and kit
US8387798B1 (en) 2012-04-27 2013-03-05 Abdulmohsen E. A. H. Al-Terki Mutiple oral and nasal surgical procedures method and kit
US11406671B2 (en) 2015-04-24 2022-08-09 The Translational Genomics Research Institute Compositions and methods for augmenting the nasal microbiome
CN113943679B (zh) * 2021-11-08 2023-02-03 南京农业大学 一株羊鼻腔源贝莱斯芽孢杆菌及其应用
CN115644136B (zh) * 2022-11-11 2025-07-29 河南省人民医院 一种用于阻塞性呼吸睡眠暂停综合征的微生态动物模型

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5980908A (en) * 1991-12-05 1999-11-09 Alfa Laval Ab Bacterial cell surface protein with fibronectin, fibrinogen, collagen and laminin binding ability, process for the manufacture of the protein and prophylactic treatment
SE9604844D0 (sv) * 1996-12-30 1996-12-30 Carl Gerhard Gottfries Medel för terapeutisk behandling av fibromyalgi och kroniskt trötthetssyndrom

Also Published As

Publication number Publication date
EP2358385A1 (en) 2011-08-24
CA2743649A1 (en) 2010-05-20
KR20110112803A (ko) 2011-10-13
CN102281894A (zh) 2011-12-14
EP2358385A4 (en) 2013-08-14
AU2009316226A1 (en) 2010-05-20
US20110311588A1 (en) 2011-12-22
WO2010054424A1 (en) 2010-05-20
JP2012508693A (ja) 2012-04-12
JP2015180689A (ja) 2015-10-15

Similar Documents

Publication Publication Date Title
RU2468807C2 (ru) Детское питание, содержащее инактивированный пробиотик
Pregliasco et al. A new chance of preventing winter diseases by the administration of synbiotic formulations
US20060177424A1 (en) Treatment of disease states and adverse physiological conditions utilizing anti-fungal compositions
KR20190133640A (ko) 락토바실러스 가세리 kbl697 균주 및 그 용도
KR101166798B1 (ko) 락토바실러스 애시도필러스 엘비의 사균을 포함하는 알레르기 질환의 치료 또는 예방용 의약 조성물
TWI504392B (zh) A medical composition or food and drink for hyperthyroidism
US11801275B2 (en) Compositions and methods for common colds
JP2022504792A (ja) 炎症性疾患及び関連する感染の治療方法
US20110311588A1 (en) Agents and treatment for snoring and respiratory effort related arousals in sleep
WO2007125566A2 (en) Use of probiotics in the prevention and treatment of allergic conjunctivitis
CA3058818A1 (en) Compositions and methods for treating parkinson's disease (pd) and related disorders
Anilkumar et al. Role of friendly bacteria in oral health-a short review.
CN116019837B (zh) 约氏副拟杆菌dsm18315在预防或治疗肥胖或其相关疾病中的应用
CN119584873A (zh) 组合物及其用途
US6767537B2 (en) Composition and method for the treatment of sinusitis
WO2007133188A1 (en) Treatment of disease states and adverse physiological conditions utilizing anti-fungal compositions
WO2021214661A1 (en) Oral composition comprising s-adenosyl methionine and a probiotic and its use for treating and/or preventing mood disorders
Banik et al. Efficacy of Lactobacillus reuteri in improving gut barrier function & management of infantile colic
US11020440B2 (en) Probiotic for the treatment of psoriasis
Bal et al. Vaginal and rectal delivery of probiotics
Marom et al. Complementary and alternative medicine for otitis media
US20230041103A1 (en) Composition for the prevention and treatment of dysbiosis
CN120000694A (zh) 一种用于缓解呼吸道不适的组合物及其应用和产品
Wu et al. Evaluation of efficacy and safety of
Liben 27 Respiratory symptoms

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired